The impact of the COVID-19 pandemic on antimicrobial resistance: a debate
David van Duin, Gavin Barlow, Dilip Nathwani
Abstract
Abstract The coronavirus disease 2019 (COVID-19) pandemic is having an enormous impact on public health. Infection with SARS-CoV-2 has become a leading cause of morbidity and mortality in many regions around the world. As many COVID-19 patients are treated with antibiotics, there is concern regarding an associated rise in rates of antimicrobial resistance (AMR). On the other hand, social distancing, isolation and reduced travel may result in decreased spread of AMR. In this issue of JAC-Antimicrobial Resistance, we present a PRO/CON debate on the question of the potential impact of COVID-19 on AMR rates.
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)Antibiotic resistanceSocial distanceIsolation (microbiology)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntimicrobialCoronavirusPublic healthResistance (ecology)Intensive care medicineDiseaseMedicineVirologyDevelopment economicsInfectious disease (medical specialty)AntibioticsBiologyMicrobiologyOutbreakEconomicsInternal medicinePathologyEcologyAntibiotic Use and ResistanceCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies